Type 1 diabetes (T1D) is related to the autoimmune destruction of β-cells, leading to their almost complete absence in patients with longstanding T1D. However, endogenous insulin secretion persists in such patients as evidenced by the measurement of plasma C-peptide. Recently, a low level of insulin has been found in non-β islet cells of patients with longstanding T1D, indicating that other islet cell types may contribute to persistent insulin secretion. The present study aimed to test the ability of various antibodies to detect insulin in insulin-deficient islets of T1D patients. Pancreatic autopsies from two children with recent-onset T1D, two adults with longstanding T1D, and three control subjects were examined using double immunofluorescent labeling with antibodies to insulin, glucagon and somatostatin. Immunoreactivity to insulin in glucagon+ cells of insulin-deficient islets was revealed using polyclonal antibodies and monoclonal antibodies simultaneously recognizing insulin and proinsulin. Along with this, immunoreactivity to insulin was observed in the majority of glucagon+ cells of insulin-containing islets of control subjects and children with recent-onset T1D. These results suggest that islet α-cells may contain insulin and/or other insulin-like proteins (proinsulin, C-peptide). Future studies are needed to evaluate the role of α-cells in insulin secretion and diabetes pathogenesis.

Download full-text PDF

Source
http://dx.doi.org/10.3390/life15010125DOI Listing

Publication Analysis

Top Keywords

insulin-deficient islets
12
longstanding t1d
12
insulin secretion
12
insulin
10
insulin insulin-deficient
8
type diabetes
8
patients longstanding
8
children recent-onset
8
recent-onset t1d
8
control subjects
8

Similar Publications

Type 1 diabetes (T1D) is related to the autoimmune destruction of β-cells, leading to their almost complete absence in patients with longstanding T1D. However, endogenous insulin secretion persists in such patients as evidenced by the measurement of plasma C-peptide. Recently, a low level of insulin has been found in non-β islet cells of patients with longstanding T1D, indicating that other islet cell types may contribute to persistent insulin secretion.

View Article and Find Full Text PDF

: Adipsin, an adipokine, is known to play an important role in maintaining the function of pancreatic beta cells in mice. This study aimed to investigate whether adipsin could be a circulating biomarker for evaluating the function of beta cells in patients with type 2 diabetes (T2D). : Plasma adipsin concentrations were measured using immunoassay in three distinct subject groups: normoglycemia, T2D without insulin treatment (T2D-w/o-insulin), and T2D treated with insulin (T2D-with-insulin).

View Article and Find Full Text PDF
Article Synopsis
  • Slowly Progressive Insulin-Dependent Diabetes Mellitus (SPIDDM) is a subtype of type 1 diabetes, often seen in Japanese children, but there are limited studies on it.
  • The case study followed two pediatric SPIDDM patients over several years, revealing different patterns in insulin deficiency and autoantibodies.
  • The research highlights the importance of monitoring insulin secretory capacity and autoantibodies to differentiate SPIDDM from type 2 diabetes, especially in young, non-obese patients.
View Article and Find Full Text PDF
Article Synopsis
  • The nPOD-Virus group investigated the presence of viral RNA in pancreas and other tissues from organ donors, specifically focusing on type 1 diabetes samples, using advanced technologies and a large collection of pancreas samples.
  • The study included pancreas, spleen, and other tissue samples from various donor groups, analyzing them with methods like RNA sequencing and RT-PCR to uncover viral infections.
  • Results showed that enterovirus RNA was detected primarily in certain donor groups, with significantly higher rates in those with single islet autoantibodies compared to type 1 diabetes donors and control donors, indicating a possible link between enterovirus and autoimmunity in diabetes.
View Article and Find Full Text PDF

An unmet need: Pancreatic beta cell replacement.

S Afr Med J

April 2024

Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.

Diabetes mellitus (DM) is a growing public health concern in South Africa (SA) and poses a substantial economic burden on healthcare globally. A century has passed since the discovery of insulin, and despite advances in diabetes management, exogenous insulin remains a primary treatment for type 1 DM, posing challenges of hyperglycaemia and hypoglycaemia. Pancreas transplantation should be considered a treatment for insulin-deficient DM, offering sustained euglycaemia and preventing complications associated with the disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!